Broad Applications
See What You’re Missing.
The promise of precision medicine is to deliver highly targeted treatment to every single diseased cell.
The current one-size-fits-all approach of medical treatments isn’t working for many patients who need help. To move precision medicine forward, researchers and clinicians need to look at the origins of disease — the single cell — in meaningful new ways.
Tapestri®
The Precision Genomics Platform™
- Targeted and accurate SNVs and indel variant calling
- Single-cell DNA throughput up to 10,000 cells
- High sensitivity – Detect rare subclones down to 0.1%
- Identify mutation co-occurrence
- Resolve clonal architecture
- Simple workflow
- User-friendly bioinformatics software
- Customizable content
-
"No technology prior to Tapestri has been able to give us the resolution to decipher co-occurring mutations in the same clones. These insights are especially important in our study of resistance mechanisms and combinatorial therapies in key clinical trials."
- Catherine Smith, MD
-
“To accelerate the understanding of response, resistance, and relapse, it is important to move away from bulk sequencing and make single-cell analysis routine.”
- Jerry Radich, MD
-
"This new capability of single-cell analysis is critical to better understanding precision therapy selection at diagnosis as well as disease monitoring and subsequent treatment strategy.”
- Koichi Takahashi, MD
-
"We use cutting edge single-cell techniques like the Tapestri Platform to give us insights into the selective advantages certain mutations confer in hematopoietic stem and progenitor cells, along with examining clonal heterogeneity including in the detection of minimal residual disease."
- Ross Levine, MD
-
"We have a profound gap in knowledge between the interaction of a person, their cancer, and their therapy and how that impacts response. We need better insight"
- Jerry Radich, MD
